Cytokine signature in convalescent SARS-CoV-2 patients with inflammatory bowel disease receiving vedolizumab

ABSTRACT:

SUBMITTER: Dallari S 

PROVIDER: S-EPMC10761911 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature